Overcoming non-specific adsorption issues for AZD9164 in human urine samples: consideration of bioanalytical and metabolite identification procedures.

@article{Silvester2012OvercomingNA,
  title={Overcoming non-specific adsorption issues for AZD9164 in human urine samples: consideration of bioanalytical and metabolite identification procedures.},
  author={S. Silvester and Frank Zang},
  journal={Journal of chromatography. B, Analytical technologies in the biomedical and life sciences},
  year={2012},
  volume={893-894},
  pages={
          134-43
        }
}
  • S. Silvester, Frank Zang
  • Published 2012
  • Chemistry, Medicine
  • Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
    • A key challenge in the development of robust bioanalytical methods, for the determination of drug analyte in human urine samples, is the elimination of potential analyte losses as a result of non-specific adsorption to container surfaces in which the samples are collected, stored or processed. A common approach to address adsorption issues is to treat the urine samples with additives that serve to increase analyte solubility and/or minimise interaction with the container surfaces. A series of… CONTINUE READING
    View on PubMed
    doi.org
    18 Citations
    Background Citations
    1
    18 Citations
    Citation Type

    Citation Type

    Approach to reduce the non-specific binding in microdialysis
    • 20
    Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials
    • 2
    • PDF
    Preparation of urine samples prior to targeted or untargeted metabolomics mass-spectrometry analysis
    • 78
    Micelle assisted thin-film solid phase microextraction: a new approach for determination of quaternary ammonium compounds in environmental samples.
    • 27
    • PDF
    LC-MS/MS determination of alectinib and its major human metabolite M4 in human urine: prevention of nonspecific binding.
    • 2
    One-step polymer surface modification for minimizing drug, protein, and DNA adsorption in microanalytical systems.
    • 15
    • PDF
    Regulated Bioanalysis—Historical Aspects and Key Concepts Related to Its Use
    The key points in the pre-analytical procedures of blood and urine samples in metabolomics studies
    • 4
    Case studies: the impact of nonanalyte components on LC-MS/MS-based bioanalysis: strategies for identifying and overcoming matrix effects.
    • 18
    The development and validation of a novel LC-MS/MS method for the quantification of Cenicriviroc in human plasma and cerebrospinal fluid.
    • 1

    References

    SHOWING 1-10 OF 22 REFERENCES
    Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine.
    • 33
    Quantitative determination of BAF312, a S1P-R modulator, in human urine by LC-MS/MS: prevention and recovery of lost analyte due to container surface adsorption.
    • 37
    Challenges in urine bioanalytical assays: overcoming nonspecific binding.
    • 65
    HPLC-MS/MS determination of a hardly soluble drug in human urine through drug-albumin binding assisted dissolution.
    • R. Rodila, G. Kim, +4 authors T. El-Shourbagy
    • Chemistry, Medicine
    • Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
    • 2008
    • 7
    Sensitive and cost-effective LC-MS/MS method for quantitation of CVT-6883 in human urine using sodium dodecylbenzenesulfonate additive to eliminate adsorptive losses.
    • 19
    Development of methods to monitor ionization modification from dosing vehicles and phospholipids in study samples.
    • 10
    Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: issues concerning assay specificity and quality control preparation.
    • 13
    Stabilization and determination of a PPAR agonist in human urine using automated 96-well liquid-liquid extraction and liquid chromatography/tandem mass spectrometry.
    • 14
    The effect of beta-cyclodextrin on liquid chromatography/electrospray-mass spectrometry analysis of hydrophobic drug molecules.
    • 8
    Determination of a cyclic hexapeptide (L-743 872), a novel pneumocandin antifungal agent in human plasma and urine by high-performance liquid chromatography with fluorescence detection
    • 58